AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

ASX:EMVEMvision Medical Devices Stock Price, Forecast & News

A$0.92
-0.02 (-2.14 %)
(As of 05/13/2020)
Add
Compare
Today's Range
A$0.88
Now: A$0.92
A$0.94
50-Day Range
A$0.67
MA: A$0.85
A$0.96
52-Week Range
A$0.36
Now: A$0.92
A$1.00
Volume192,157 shs
Average VolumeN/A
Market Capitalization$58.25 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
EMvision Medical Devices Limited focuses on developing and commercializing medical imaging devices using electromagnetic microwave imaging for diagnosing stroke and other medical applications in Europe and Australia. It intends to offer brain scanner, a portable clinical prototype that utilizes the EMvision technology to create three dimensional images of the human brain. EMvision Medical Devices Limited has a strategic collaboration with Keysight Technologies Malaysia Sdn Bhd to develop a personalized vector network analysis solution for medical imaging in the healthcare sector. The company was founded in 2017 and is based in Brisbane, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.86 out of 5 stars


Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 2 8667 5337

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.86 million
Cash FlowA$0.11 per share
Book ValueA$0.11 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$58.25 million
Next Earnings DateN/A
OptionableNot Optionable

Receive EMV News and Ratings via Email

Sign-up to receive the latest news and ratings for EMV and its competitors with MarketBeat's FREE daily newsletter.

EMvision Medical Devices (ASX:EMV) Frequently Asked Questions

How has EMvision Medical Devices' stock been impacted by COVID-19 (Coronavirus)?

EMvision Medical Devices' stock was trading at A$0.65 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, EMV shares have increased by 40.8% and is now trading at A$0.92. View which stocks have been most impacted by Coronavirus.

How were EMvision Medical Devices' earnings last quarter?

EMvision Medical Devices Ltd (ASX:EMV) released its quarterly earnings data on Tuesday, February, 26th. The company reported ($4.47) earnings per share (EPS) for the quarter. View EMvision Medical Devices' earnings history.

Has EMvision Medical Devices been receiving favorable news coverage?

Press coverage about EMV stock has trended very negative this week, InfoTrie reports. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. EMvision Medical Devices earned a media sentiment score of -3.5 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutEMvision Medical Devices.

Who are some of EMvision Medical Devices' key competitors?

Who are EMvision Medical Devices' key executives?

EMvision Medical Devices' management team includes the following people:
  • Mr. John Keep, Exec. Chairman
  • Dr. Ronald Peter Weinberger, Chief Exec. Officer
  • Ms. Emma Waldon, CFO & Company Sec. (Age 43)
  • Mr. Scott Kirkland, Exec. Director

What is EMvision Medical Devices' stock symbol?

EMvision Medical Devices trades on the ASX under the ticker symbol "EMV."

What is EMvision Medical Devices' stock price today?

One share of EMV stock can currently be purchased for approximately A$0.92.

How big of a company is EMvision Medical Devices?

EMvision Medical Devices has a market capitalization of $58.25 million and generates $1.86 million in revenue each year.

What is EMvision Medical Devices' official website?

The official website for EMvision Medical Devices is www.emvision.com.au.

How can I contact EMvision Medical Devices?

The company can be reached via phone at 61 2 8667 5337.

This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.